Which medication is indicated for treating hypertension in a patient with hypertrophic cardiomyopathy?

Metoprolol is a beta-blocker that plays a crucial role in the management of hypertension, especially in patients with hypertrophic cardiomyopathy (HCM). The significance of using metoprolol lies in its ability to reduce heart rate and contractility, which helps decrease the outflow tract obstruction commonly seen in HCM. This medication effectively alleviates symptoms such as angina, dyspnea, and syncope, which may arise due to the structural cardiac changes associated with hypertrophic cardiomyopathy.

In addition, beta-blockers like metoprolol improve diastolic function and enhance coronary artery perfusion by reducing myocardial oxygen demand, making them particularly beneficial for managing both hypertension and the specific complications that can present in HCM. This makes metoprolol a preferred choice for treating hypertension in patients with this condition, as it directly addresses the underlying issues related to cardiac function and structural abnormalities.